Search Within

Rivka Chaya Litvin

Formats
  1. Journal Article (2)
  2. Meeting Abstract (2)
Groups
  1. Adult Leukemia (4)
  2. Center for Hematologic Malignancies (4)
  3. Center for Molecular Imaging and Biotechnology (CMIB) (4)
  4. Department of Medicine (4)
  5. Executive Committee, Center for Hematologic Malignancies (4)
  6. GSK Faculty (4)

More Groups

People
  1. Raajit Rampal (4)
  2. Ross Levine (4)
  3. Anna Mckenney (2)
  4. Ellin Berman (2)
  5. Hugo Castro-Malaspina (2)
  6. Martin Tallman (2)

More People

Years
  1. 2019 (1)
  2. 2018 (1)
  3. 2016 (1)
  4. 2015 (1)
Publications
  1. Blood (2)
  2. Biology of Blood and Marrow Transplantation (1)
  3. Haematologica (1)
Publishers
  1. American Society of Hematology (2)
  2. Elsevier Inc. (1)
  3. Ferrata Storti Foundation (1)

Results (4)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of high-molecular-risk mutations on transplantation outcomes in patients with myelofibrosis
    Journal Article

    Tamari, R.; Rapaport, F.; Zhang, N.; McNamara, C.; Kuykendall, A.; Sallman, D. A.; Komrokji, R.; Arruda, A.; Najfeld, V.; Sandy, L.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Hsp90 inhibition disrupts JAK-STAT signaling and leads to reductions in splenomegaly in patients with myeloproliferative neoplasms
    Journal Article

    Hobbs, G. S.; Hanasoge Somasundara, A. V.; Kleppe, M.; Litvin, R.; Arcila, M.; Ahn, J.; McKenney, A. S.; Knapp, K.; Ptashkin, R.; Weinstein, H.; more...
    Haematologica (2018)

    Fulltext@MSK | Save
  • Impact of genomic alterations on outcomes in myelofibrosis patients undergoing allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Rampal, R. K.; Tamari, R.; Zhang, N.; McNamara, C. J.; Rapaport, F.; Litvin, R.; Maloy, M. A.; Castro-Malaspina, H.; Giralt, S.; Weinberg, R. S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • AUY922, a Heat Shock Protein 90 (Hsp90) inhibitor, demonstrates activity in patients with myeloproliferative neoplasms (MPNs)
    Meeting Abstract

    Hobbs, G.; Litvin, R.; Ahn, J.; McKenney, A. S.; Mauro, M. J.; Tallman, M. S.; Berman, E.; Heaney, M. L.; Levine, R. L.; Rampal, R. K.
    Blood (2015)

    Fulltext@MSK | Save